Literature DB >> 15388447

Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae.

Sarit Markovich1, Aya Yekutiel, Itamar Shalit, Yona Shadkchan, Nir Osherov.   

Abstract

The antifungal agent caspofungin (CAS) specifically interferes with glucan synthesis and cell wall formation. To further study the cellular processes affected by CAS, we analyzed a Saccharomyces cerevisiae mutant collection (4,787 individual knockout mutations) to identify new genes affecting susceptibility to the drug. This collection was screened for increased CAS sensitivity (CAS-IS) or increased CAS resistance (CAS-IR). MICs were determined by the broth microdilution method. Disruption of 20 genes led to CAS-IS (four- to eightfold reductions in the MIC). Eleven of the 20 genes are involved in cell wall and membrane function, notably in the protein kinase C (PKC) integrity pathway (MID2, FKS1, SMI1, and BCK1), chitin and mannan biosynthesis (CHS3, CHS4, CHS7, and MNN10), and ergosterol biosynthesis (ERG5 and ERG6). Four of the 20 genes (TPO1, VPS65, VPS25, and CHC1) are involved in vacuole and transport functions, 3 of the 20 genes (CCR4, POP2, and NPL3) are involved in the control of transcription, and 2 of the 20 genes are of unknown function. Disruption of nine additional genes led to CAS-IR (a fourfold increase of MIC). Five of these nine genes (SLG1, ERG3, VRP1, CSG2, and CKA2) are involved in cell wall function and signal transduction, and two of the nine genes (VPS67 and SAC2) are involved in vacuole function. To assess the specificity of susceptibility to CAS, the MICs of amphotericin B, fluconazole, flucytosine, and calcofluor for the strains were tested. Seven of 20 CAS-IS strains (with disruption of FKS1, SMI1, BCK1, CHS4, ERG5, TPO1, and ILM1) and 1 of 9 CAS-IR strains (with disruption of SLG1) demonstrated selective susceptibility to CAS. To further explore the importance of PKC in CAS susceptibility, the activity of the PKC inhibitor staurosporine in combination with CAS was tested against eight Aspergillus clinical isolates by the microdilution assay. Synergistic or synergistic-to-additive activities were found against all eight isolates by use of both MIC and minimum effective concentration endpoints.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388447      PMCID: PMC521896          DOI: 10.1128/AAC.48.10.3871-3876.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

Authors:  Sevtap Arikan; Mario Lozano-Chiu; Victor Paetznick; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans.

Authors:  M Del Poeta; M C Cruz; M E Cardenas; J R Perfect; J Heitman
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

3.  Characterization of staurosporine-sensitive mutants of Saccharomyces cerevisiae: vacuolar functions affect staurosporine sensitivity.

Authors:  S Yoshida; Y Anraku
Journal:  Mol Gen Genet       Date:  2000-06

4.  Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis.

Authors:  E A Winzeler; D D Shoemaker; A Astromoff; H Liang; K Anderson; B Andre; R Bangham; R Benito; J D Boeke; H Bussey; A M Chu; C Connelly; K Davis; F Dietrich; S W Dow; M El Bakkoury; F Foury; S H Friend; E Gentalen; G Giaever; J H Hegemann; T Jones; M Laub; H Liao; N Liebundguth; D J Lockhart; A Lucau-Danila; M Lussier; N M'Rabet; P Menard; M Mittmann; C Pai; C Rebischung; J L Revuelta; L Riles; C J Roberts; P Ross-MacDonald; B Scherens; M Snyder; S Sookhai-Mahadeo; R K Storms; S Véronneau; M Voet; G Volckaert; T R Ward; R Wysocki; G S Yen; K Yu; K Zimmermann; P Philippsen; M Johnston; R W Davis
Journal:  Science       Date:  1999-08-06       Impact factor: 47.728

5.  Screening the yeast "disruptome" for mutants affecting resistance to the immunosuppressive drug, mycophenolic acid.

Authors:  Christine Desmoucelles; Benoit Pinson; Christelle Saint-Marc; Bertrand Daignan-Fornier
Journal:  J Biol Chem       Date:  2002-05-16       Impact factor: 5.157

6.  A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR).

Authors:  T F Chan; J Carvalho; L Riles; X F Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

7.  Overexpression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae.

Authors:  Nir Osherov; Gregory S May; Nathaniel D Albert; D P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 8.  Chitin synthesis as target for antifungal drugs.

Authors:  J Ruiz-Herrera; G San-Blas
Journal:  Curr Drug Targets Infect Disord       Date:  2003-03

9.  Genome-wide screening of Saccharomyces cerevisiae to identify genes required for antibiotic insusceptibility of eukaryotes.

Authors:  Alexandra S Blackburn; Simon V Avery
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

10.  Dissection of upstream regulatory components of the Rho1p effector, 1,3-beta-glucan synthase, in Saccharomyces cerevisiae.

Authors:  Mariko Sekiya-Kawasaki; Mitsuhiro Abe; Ayaka Saka; Daisuke Watanabe; Keiko Kono; Masayo Minemura-Asakawa; Satoru Ishihara; Takahide Watanabe; Yoshikazu Ohya
Journal:  Genetics       Date:  2002-10       Impact factor: 4.562

View more
  48 in total

Review 1.  Type 2C protein phosphatases in fungi.

Authors:  Joaquín Ariño; Antonio Casamayor; Asier González
Journal:  Eukaryot Cell       Date:  2010-11-12

Review 2.  Transport according to GARP: receiving retrograde cargo at the trans-Golgi network.

Authors:  Juan S Bonifacino; Aitor Hierro
Journal:  Trends Cell Biol       Date:  2010-12-21       Impact factor: 20.808

3.  The 'interactome' of the Knr4/Smi1, a protein implicated in coordinating cell wall synthesis with bud emergence in Saccharomyces cerevisiae.

Authors:  Fadi Basmaji; Hélène Martin-Yken; Fabien Durand; Adilia Dagkessamanskaia; Carole Pichereaux; Michel Rossignol; Jean Francois
Journal:  Mol Genet Genomics       Date:  2005-12-16       Impact factor: 3.291

Review 4.  Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.

Authors:  Leah E Cowen; William J Steinbach
Journal:  Eukaryot Cell       Date:  2008-03-28

Review 5.  Resistance to echinocandin-class antifungal drugs.

Authors:  David S Perlin
Journal:  Drug Resist Updat       Date:  2007-06-13       Impact factor: 18.500

6.  Attenuation of the activity of caspofungin at high concentrations against candida albicans: possible role of cell wall integrity and calcineurin pathways.

Authors:  Nathan P Wiederhold; Dimitrios P Kontoyiannis; Randall A Prince; Russell E Lewis
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

7.  Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints.

Authors:  Guillermo Garcia-Effron; Steven Park; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

8.  Inhibitory Role of Greatwall-Like Protein Kinase Rim15p in Alcoholic Fermentation via Upregulating the UDP-Glucose Synthesis Pathway in Saccharomyces cerevisiae.

Authors:  Daisuke Watanabe; Yan Zhou; Aiko Hirata; Yukiko Sugimoto; Kenichi Takagi; Takeshi Akao; Yoshikazu Ohya; Hiroshi Takagi; Hitoshi Shimoi
Journal:  Appl Environ Microbiol       Date:  2015-10-23       Impact factor: 4.792

9.  CRS-MIS in Candida glabrata: sphingolipids modulate echinocandin-Fks interaction.

Authors:  Kelley R Healey; Santosh K Katiyar; Shriya Raj; Thomas D Edlind
Journal:  Mol Microbiol       Date:  2012-08-22       Impact factor: 3.501

10.  Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin.

Authors:  Sheena D Singh; Nicole Robbins; Aimee K Zaas; Wiley A Schell; John R Perfect; Leah E Cowen
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.